Mikart Capabilities Update March 2026: Small Molecule Drug Product

This presentation will highlight Mikart’s comprehensive capabilities in small molecule drug product development and manufacturing, spanning formulation design, process optimization, scale-up, and commercial production. Attendees will gain insight into the company’s scientific and technical expertise, as well as its approach to delivering robust, reproducible formulations that meet regulatory and performance expectations.

In addition, the session will provide an overview of Mikart’s facility infrastructure, specialized technologies, and manufacturing capacity, all designed to support dependable and scalable programs. From early development through full commercialization, discover how Mikart ensures continuity, quality, and flexibility to help advance products efficiently to market.